Electrifying the Factory: Agentic AI For Faster Clinical Trials with Pamela Tenaerts
Send us Fan Mail
The clinical trial system is starting to look like a motorway at a standstill: more and more drugs are lining up, but the lanes ahead are already full. We sit down with Pamela Tenart to unpack why the industry may have reached the limit of human-only clinical development, and why “adding more people” is no longer a realistic plan when experienced CRAs, site co-ordinators and trial operators are already stretched thin.
From there, we get practical about what agentic AI could change inside clinical trial operations. We talk about AI agents that can pull context across CTMS…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.